261 related articles for article (PubMed ID: 17213279)
1. Plasma adiponectin concentrations and risk of incident breast cancer.
Tworoger SS; Eliassen AH; Kelesidis T; Colditz GA; Willett WC; Mantzoros CS; Hankinson SE
J Clin Endocrinol Metab; 2007 Apr; 92(4):1510-6. PubMed ID: 17213279
[TBL] [Abstract][Full Text] [Related]
2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
4. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
6. Adult weight change and risk of postmenopausal breast cancer.
Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
JAMA; 2006 Jul; 296(2):193-201. PubMed ID: 16835425
[TBL] [Abstract][Full Text] [Related]
7. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.
Eliassen AH; Zeleniuch-Jacquotte A; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):854-60. PubMed ID: 26961996
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
9. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
11. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
12. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
13. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
Eliassen AH; Tworoger SS; Hankinson SE
Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
[TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
[TBL] [Abstract][Full Text] [Related]
15. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Manson JE; Colditz GA; Hunter DJ; Spiegelman D; Barbieri RL; Speizer FE
J Natl Cancer Inst; 1998 Sep; 90(17):1292-9. PubMed ID: 9731736
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of weight and weight gain on breast cancer risk.
Huang Z; Hankinson SE; Colditz GA; Stampfer MJ; Hunter DJ; Manson JE; Hennekens CH; Rosner B; Speizer FE; Willett WC
JAMA; 1997 Nov; 278(17):1407-11. PubMed ID: 9355998
[TBL] [Abstract][Full Text] [Related]
18. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
19. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
20. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
